v3.23.2
BACKGROUND AND ORGANIZATION (Details Narrative)
 3 Months Ended 6 Months Ended 12 Months Ended
Aug. 30, 2022
$ / shares
shares
Jun. 30, 2023
USD ($)
$ / shares
shares
Mar. 31, 2023
USD ($)
Jun. 30, 2022
USD ($)
shares
Mar. 31, 2022
USD ($)
Jun. 30, 2023
USD ($)
$ / shares
shares
Jun. 30, 2022
USD ($)
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Jan. 02, 2023
shares
Aug. 30, 2022
₨ / shares
shares
Mar. 17, 2021
$ / shares
shares
Sep. 21, 2018
$ / shares
shares
Oct. 05, 2017
$ / shares
shares
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                            
Common stock, shares authorized   300,000,000       300,000,000   300,000,000 300,000,000          
Common stock, par value | $ / shares   $ 0.001       $ 0.001   $ 0.001 $ 0.001          
Common stock, shares authorized   50,000,000       50,000,000   50,000,000 50,000,000          
Preferred stock, par value | $ / shares   $ 0.001       $ 0.001   $ 0.001 $ 0.001          
Net loss attributable to the non-controlling interest | $   $ 764 $ 32,894 $ 11,691 $ 51,116 $ 33,658 $ 62,807 $ 193,372 $ 496,297          
Common stock, shares issued   132,035,294   0   132,035,294 0 123,252,235 110,840,998 123,252,235        
Common stock, shares outstanding   132,035,294   0   132,035,294 0 123,252,235 110,840,998 123,252,235        
Pharmalectin B V I [Member]                            
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                            
Common stock, shares authorized                       50,000    
Common stock, par value | $ / shares                       $ 1.00    
Common stock, shares outstanding   50,000       50,000                
Pharmalectin India Pvt Ltd [Member]                            
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                            
Common stock, shares authorized 50,000                   50,000      
Common stock, par value | (per share) $ 0.12                   ₨ 10      
Common stock, shares outstanding 41,020                   41,020      
[custom:CommonStockSharesOutstandingRoundOff-0] 41,000                   41,000      
[custom:PercentageOfOutstandingShares] 99.95%                          
Pharmalectin, Inc. [Member]                            
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                            
Non-controlling interest percentage               85.00%            
Parent Company [Member]                            
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                            
Common stock, shares authorized                         300,000,000 95,000,000
Common stock, par value | $ / shares                         $ 0.001 $ 0.0001
Common stock, shares authorized                         50,000,000 5,000,000
Preferred stock, par value | $ / shares                         $ 0.001 $ 0.0001
Pharmalectin, Inc. [Member]                            
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                            
Common stock, shares authorized                           95,000,000
Common stock, par value | $ / shares                           $ 0.0001
Common stock, shares authorized                           5,000,000
Preferred stock, par value | $ / shares                           $ 0.0001
Common stock, shares issued   30,000,000       30,000,000   30,000,000 30,000,000          
Common stock, shares outstanding   19,650,000       19,650,000   19,650,000 19,650,000          
Pharmalectin, Inc. [Member] | Parent Company [Member]                            
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                            
Common stock, shares outstanding   15,000,000       15,000,000   15,000,000 15,000,000          
Pharmalectin, Inc. [Member] | Affiliate [Member]                            
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                            
Common stock, shares outstanding   4,650,000       4,650,000   4,650,000            
Options outstanding   4,500,000       4,500,000   4,500,000